Find similar products:
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL 41871/0011.
Carbamazepine Essential Pharma 125 and 250 mg Suppositories
Carbamazepine Essential Pharma 125 and 250 mg Suppositories
1. What Carbamazepine Essential Pharma Suppositories are and what they are used for
2. What you need to know before you use Carbamazepine Essential Pharma Suppositories
3. How to use Carbamazepine Essential Pharma Suppositories
4. Possible side effects
5. How to store Carbamazepine Essential Pharma Suppositories
6. Contents of the pack and other information
Carbamazepine, the active ingredient in Carbamazepine Essential Pharma Suppositories, is an anti-convulsant medicine (prevents fits).
Carbamazepine Essential Pharma Suppositories are used to treat some forms of epilepsy. They are useful in the short term, (maximum 7 days), for patients who cannot take medicines by mouth, e.g. after surgery or if unconscious.
Your doctor may want you to have a number of blood tests before you are treated with Carbamazepine and sometimes during your treatment. This is quite usual and nothing to worry about.
A small number of people being treated with anti-epileptics such as carbamazepine have had thoughts of harming or killing themselves. If at any time you have these thoughts, immediately contact your doctor.
If you experience any of the below signs and symptoms suggestive of allergic reactions, stop taking carbamazepine and contact your doctor immediately:
Some people may have a reduced response to carbamazepine treatment, if they bear a specific genetic variant of a transporter protein (ABCB1 transporter). If carbamazepine is not working as expected and your disease is not adequately controlled, your doctor may decide to test you for the presence of this specific gene and adjust the treatment.
If you experience dizziness, drowsiness, decrease in blood pressure, confusion, due to carbamazepine treatment, this may lead to falls.
You should also ask yourself these questions before you use Carbamazepine Essential Pharma Suppositories. If the answer to any of these questions is YES, discuss your treatment with your doctor or pharmacist because Carbamazepine Essential Pharma Suppositories might not be the right medicine for you.
There is a risk of harm to the unborn child if Carbamazepine Essential Pharma is used during pregnancy. Women of childbearing age should use effective contraception during treatment with Carbamazepine Essential Pharma and for at least two weeks after the last dose (see Pregnancy and breast-feeding).
It is important to tell your doctor or pharmacist if you are taking any other medicines for epilepsy at the same time as carbamazepine and you are pregnant, think you may be pregnant, or are planning to have a baby (see also the information in Section 2 on pregnancy and breast-feeding).
Because of the way that Carbamazepine Essential Pharma works, it can affect, and be affected by, lots of other things that you might be eating or medicines that you are taking. It is very important to make sure that your doctor knows all about what else you are taking, including anything that you have bought from a chemist or health food shop. It may be necessary to change the dose of some medicines or stop taking something altogether.
Tell the doctor if you are taking
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
If you are a woman who is able to have a baby and are not planning a pregnancy, you should use effective contraception during treatment with Carbamazepine Essential Pharma. Carbamazepine Essential Pharma may affect how hormonal contraceptives, such as the contraceptive (birth control) pill, work and make them less effective at preventing pregnancy. Talk to your doctor, who will discuss with you the most suitable type of contraception to use while you are taking Carbamazepine Essential Pharma. If treatment with Carbamazepine Essential Pharma is discontinued you should continue using effective contraception for at least two more weeks following discontinuation.
If you are pregnant, or think you may be pregnant, you must tell your doctor straight away and discuss possible risks the epilepsy medicine you are taking might pose to your unborn baby.
If you are planning to become pregnant you should discuss your epilepsy treatment with your doctor as early as possible before you become pregnant.
You should not stop your treatment without discussing this with your doctor. Suddenly stopping may lead to breakthrough seizures which may harm you and your unborn baby. It is important that your epilepsy remains well controlled.
Taking carbamazepine during pregnancy increases the chance that the baby may have a physical birth abnormality (major congenital malformations). Studies with women treated with carbamazepine for epilepsy have shown that on average 4-5 babies in every 100 will have serious physical birth abnormalities. This is compared with 2 to 3 babies in every 100 born to women who do not have epilepsy.
These abnormalities can develop early in pregnancy, even before you know you are pregnant. The most common types of major congenital malformations reported for carbamazepine include spina bifida (where the bones of the spine are not properly developed); facial and skull malformations including cleft lip/palate; skeletal, heart, urinary tract and sexual organ malformations.
Studies have found that the risk of physical birth abnormalities increases with increasing doses of carbamazepine. Therefore, it is important that where possible you are prescribed the lowest dose to control your epilepsy.
Problems with neurodevelopment (development of the brain) have been reported in babies born to mothers who used carbamazepine during pregnancy. Some studies have shown that carbamazepine negatively affects neurodevelopment of children exposed to carbamazepine in the womb, while other studies have not found such an effect. The possibility of an effect on neurodevelopment cannot be ruled out.
Ask your doctor about taking folic acid when trying for a baby and during pregnancy. Folic acid may lower the general risk of serious physical birth abnormalities that exists with all pregnancies.
Taking more than one epilepsy medicine at the same time may also increase the risk of physical birth abnormalities. This means that where possible, your doctor should consider using one epilepsy medicine to control your epilepsy.
Studies suggest that taking carbamazepine during pregnancy does not increase the risk the child may have difficulties with learning and thinking ability.
If you take Carbamazepine Essential Pharma Suppositories during pregnancy, your baby is also at risk for bleeding problems right after birth. Your doctor may give you and your baby a medicine to prevent this.
Breast-feeding
Mothers being treated with Carbamazepine Essential Pharma Suppositories can breastfeed their babies, but you must tell the doctor as soon as possible if you think that the baby is suffering side effects such as excessive sleepiness, skin reaction or yellow skin and eyes, dark urine or pale stools.
Fertility (Women of childbearing potential)
You should use an effective method of contraception throughout your treatment with Carbamazepine Essential Pharma Suppositories and for a period of 28 days, after discontinuation of treatment. Irregularity of the menstrual period may occur in women taking hormonal contraceptives (birth control medicines) and Carbamazepine Essential Pharma Suppositories. The hormonal contraceptive may become less effective and you should consider using a different or additional non-hormonal contraceptive method. Ask your doctor about effective contraception.
Carbamazepine Essential Pharma Suppositories can make you feel dizzy or drowsy, or may cause blurred vision, double vision, or you may have a lack of muscular coordination, especially at the start of treatment or when the dose is changed. If you are affected in this way, or if your eyesight is affected, you should not drive or operate machinery.
The doctor will tell you the dose you need. Always follow his/her instructions carefully. The dose will be on the pharmacist’s label. Check the label carefully. It is important to use the suppositories at the right times. If you are not sure, ask your doctor or pharmacist. Keep using the suppositories for as long as you have been told, unless you have any problems. In that case, check with your doctor.
Suppositories are designed to be inserted into the back passage (rectum). Never take them by mouth.
For how to insert the suppositories see the end of the leaflet.
Your doctor will work out the dose that you need. It varies from person to person.
The maximum dose is 1,000 mg per day. Elderly people might need a lower dose.
If you accidentally insert too many suppositories, or if anyone swallows any suppositories, tell your doctor or your nearest hospital casualty department. Take your pack with you so that people can see what medicine you are having.
If you forget to use a suppository, use it as soon as you remember, but if it is almost time for your next dose, skip the missed dose and continue as usual.
Do not use a double dose to make up for a missed dose.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop using the suppositories and tell your doctor straight away if you notice:
More than 1 in 10 people have experienced:
Leucopenia (a reduced number of the cells which fight infection making it easier to catch infections); dizziness and tiredness; feeling unsteady or finding it difficult to control movements; feeling or being sick; changes in liver enzyme levels (usually without any symptoms); skin reactions which may be severe.
Up to 1 in 10 people have experienced:
Changes in the blood including an increased tendency to bruise or bleed; fluid retention and swelling; weight increase; low sodium in the blood which might result in confusion; headache; double or blurred vision; dry mouth; rectal irritation.
Up to 1 in 100 people have reported:
Abnormal involuntary movements including tremor or tics; abnormal eye movements; diarrhoea; constipation.
Up to 1 in 1,000 people have reported:
Disease of the lymph glands; folic acid deficiency; a generalised allergic reaction including rash, joint pain, fever, problems with the liver, kidneys and other organs; hallucinations; depression; loss of appetite; restlessness; aggression; agitation; confusion; speech disorders; numbness or tingling in the hands and feet; muscle weakness; high blood pressure (which may make you feel dizzy, with a flushed face, headache, fatigue and nervousness); low blood pressure (the symptoms of which are feeling faint, light headed, dizzy, confused, having blurred vision); changes to heart beat; stomach pain; liver problems including jaundice; symptoms of lupus.
Up to 1 in 10,000 people have reported:
Changes to the composition of the blood including anaemia; porphyria; meningitis; swelling of the breasts and discharge of milk which may occur in both male and females; abnormal thyroid function tests; osteomalacia (which may be noticed as pain on walking and bowing of the long bones in the legs); osteoporosis; increased blood fat levels; taste disturbances; conjunctivitis; glaucoma; cataracts; hearing disorders; heart and circulatory problems including deep vein thrombosis (DVT), the symptoms of which could include tenderness, pain, swelling, warmth, skin discoloration and prominent superficial veins; lung or breathing problems; severe skin reactions including Stevens-Johnson syndrome (these reactions may be more frequent in patients of Chinese or Thai origin); sore mouth or tongue; liver failure; increased sensitivity of the skin to sunlight; alterations in skin pigmentation; acne; excessive sweating; hair loss; increased hair growth on the body and face; muscle pain or spasm; sexual difficulties which may include reduced male fertility, loss of libido or impotence; kidney failure; blood spots in the urine; increased or decreased desire to pass urine or difficulty in passing urine.
Severe skin reactions accompanied by feeling unwell and changes in blood results. Diarrhoea, abdominal pain, and fever (signs of inflammation of the colon), reactivation of herpes virus infection (can be serious when immune system is depressed), complete loss of nails, fracture, decrease in the measure of the bone density, drowsiness, memory loss, purple or reddish-purple bumps that may be itchy. High levels of ammonia in the blood (hyperammonaemia). The symptoms of hyperammonaemia may include irritability, confusion, vomiting, loss of appetite, and sleepiness.
Do not be alarmed by this list. Most people use Carbamazepine Essential Pharma Suppositories without any problems.
If any of the symptoms become troublesome, or if you notice anything else not mentioned here, please go and see your doctor. He/she may want to give you a different medicine.
There have been reports of bone disorders including osteopenia and osteoporosis (thinning of the bone) and fractures. Check with your doctor or pharmacist if you are on long-term antiepileptic medication, have a history of osteoporosis, or take steroids.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
Store below 30ºC.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and label after EXP. The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The suppositories are white or off-white in colour and come in two strengths. The lower dose contains 125 mg of carbamazepine and the suppository weighs about 1 gram. The higher dose contains 250 mg of carbamazepine and the suppository weighs about 2 grams. There are 5 suppositories in each pack.
How to insert the suppositories
The procedure is the same for a child. Once they have emptied their bowels, get them to lie down on their front or side. Gently push the suppository into the child’s back passage until it disappears. Try and stop the child moving around for a few minutes to reduce the risk of the suppository coming out.
If a doctor or nurse is giving the suppository to an unconscious patient, the procedure will be similar to that described above.
This leaflet was revised in May 2025.
Car125-250mgSupp-PL-UK-9